01 1Atidarsagen Autotemcel
02 15Burosumab
03 1CD34+ Cell-Enriched Population Transduced with Lentiviral Vector Encoding Human Arylsulfatase A Gene, Autologous Human
04 2Droperidol
05 14Fentanyl
06 1Fentanyl Citrate
07 2Granisetron
08 1Iron
09 4Mitomycin
10 2Mogamulizumab
11 1Mogamulizumabum
12 2Nitroglycerin
13 2Testosterone
14 6naloxegol
01 6Antic-calc Tablet, Film Coated
02 1Concentrate For Infusion Solution
03 2Concentrate For Solution For Infusion
04 1Dispersion For Perfusion
05 1Fentanyl 100Mcg 10 Units Sublingual Use
06 1Fentanyl 200Mcg 10 Units Sublingual Use
07 1Fentanyl 300Mcg 10 Units Sublingual Use
08 1Fentanyl 400Mcg 10 Units Sublingual Use
09 1Fentanyl 600Mcg 10 Units Sublingual Use
10 1Fentanyl 800Mcg 10 Units Sublingual Use
11 1Gel
12 1Granisetrone 3,1Mg 1 Unit Transdermal Use
13 1Infusion Solution
14 7Injectable Solution
15 3Injectable Solution In Pre-Filled Syringe
16 1Injection fluid, resolution
17 1Mitomycin 10Mg 1 Unit Parenteral Use
18 1Mitomycin 40Mg 1 Unit Parenteral Use
19 1Oral Solution
20 1Rectal Salve
21 8Solution For Injection
22 1Sublingual Tablet
23 8Sublingual tablet
24 1Transdermal patches
25 2Blank
01 11 transdermal patch 3.1 mg/24 die
02 11 vial EV 10 mg
03 11 vial EV 40 mg
04 110 cpr subling 100 mcg
05 110 cpr subling 200 mcg
06 110 cpr subling 300 mcg
07 110 cpr subling 400 mcg
08 110 cpr subling 600 mcg
09 110 cpr subling 800 mcg
10 2100 mcg
11 210MG
12 210mg
13 110mg/ml
14 212.5 mg
15 11mg/ml
16 12%
17 12-10millioncells/ml
18 12.5 mg/ml
19 12.5mg/ml
20 2200 mcg
21 220MG
22 220mg
23 120mg/ml
24 425 mg
25 13.1 mg/24 hours
26 1300 mcg
27 230MG
28 230mg
29 130mg/ml
30 14 mg/g
31 1400 mcg
32 14MG
33 14mg/5ml
34 14mg/ml
35 150mcg
36 15ML
37 1600 mcg
38 1800 mcg
39 1Gel 60 G 2%
40 1Ung Rett 30 G 4 Mg/G
41 2Blank
01 11Italy
02 1Malta
03 18Norway
04 8Spain
05 12Sweden
06 4Switzerland
01 15Abstral
02 15Crysvita
03 2Dridol
04 1Libmeldy
05 1Libmeldy 2-
06 2Mitomycin
07 2Mitomycin C
08 6Moventig
09 3Poteligeo
10 2Rectogesic
11 2Sancuso
12 1Sytron
13 1Tostran
14 1Tostrex
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Dosage Strength : 10mg
Packaging :
Brand Name : Crysvita
Approval Date : 19/02/2018
Application Number : 20161206000011
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Dosage Strength : 10mg
Packaging :
Brand Name : Crysvita
Approval Date : 30/11/2023
Application Number : 20230530000063
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Dosage Strength : 20mg
Packaging :
Brand Name : Crysvita
Approval Date : 19/02/2018
Application Number : 20161206000028
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Dosage Strength : 20mg
Packaging :
Brand Name : Crysvita
Approval Date : 30/11/2023
Application Number : 20230530000070
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Injectable Solution
Dosage Strength : 30mg
Packaging :
Brand Name : Crysvita
Approval Date : 19/02/2018
Application Number : 20161206000035
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Solution For Injection
Dosage Strength : 30mg
Packaging :
Brand Name : Crysvita
Approval Date : 30/11/2023
Application Number : 20230530000087
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Dosage Strength : 10mg/ml
Packaging :
Brand Name : Crysvita
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Dosage Form : Solution For Injection
Dosage Strength : 20mg/ml
Packaging :
Brand Name : Crysvita
Approval Date : 20/01/2020
Application Number : 66801
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Dispersion For Perfusion
Dosage Strength :
Packaging :
Brand Name : Libmeldy 2-
Approval Date : 2021-10-19
Application Number : 1201493001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Dosage Form : Injectable Solution
Dosage Strength : 20MG
Packaging :
Brand Name : Crysvita
Approval Date : 2018-05-11
Application Number : 1171262002
Regulatory Info : Authorized
Registration Country : Spain
Kyowa Kirin is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of 7-Hydroxystaurosporine bulk offered by Kyowa Kirin
Find a price of Istradefylline bulk offered by Kyowa Kirin
Find a price of Olopatadine Hydrochloride bulk offered by Kyowa Kirin
Find a price of RGI-2001 bulk offered by Kyowa Kirin
Find a price of Spicamycin Analog bulk offered by Kyowa Kirin
Find a price of KW-6356 DRUG SUBSTANCE bulk offered by Kyowa Kirin
Find a price of ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCT bulk offered by Kyowa Kirin
Contact Us!
